Legislative Information System 102nd General Assembly All Bills (Bill Order) Both Chambers Chris Crank List 4.30.21

HB 119

Short Description: PRESCRIPTION DRUG REPOSITORY

House Sponsors Rep. --Jonathan Carroll-, , , Maurice A. West, II, Dave Vella, Kelly M. Burke, Anne Stava-Murray, Andrew S. Chesney, Lindsey LaPointe, Camille Y. Lilly, , , , , Greg Harris, , Kelly M. Cassidy, , , Mike Murphy, Thomas M. Bennett, , , , Bob Morgan, , , , Norine K. Hammond, Jaime M. Andrade, Jr., Mary E. Flowers, , , , C.D. Davidsmeyer, Katie Stuart and

Senate Sponsors (Sen. and -Jacqueline Y. Collins--John Connor-)

Synopsis As Introduced Creates the Prescription Drug Repository Program Act. Requires the Department of Public Health to, by rule, establish a prescription drug repository program, under which any person may donate a prescription drug or supplies needed to administer a prescription drug for use by an individual who meets eligibility criteria specified by the Department. Sets forth requirements that prescription drugs or supplies must meet in order to be accepted and dispensed under the program. Provides that no drugs or supplies donated under the prescription drug repository program may be resold. Provides that nothing in the Act requires that a pharmacy or pharmacist participate in the prescription drug repository program. Provides for civil and criminal immunity for drug and supply manufacturers and individuals in relation to the donation, acceptance, or dispensing of prescription drugs or supplies under the prescription drug repository program. Imposes conditions on any rulemaking authority. Amends the Pharmacy Practice Act, the Wholesale Drug Distribution Licensing Act, the Senior Pharmaceutical Assistance Act, the Food, Drug and Cosmetic Act, the Illinois Controlled Substances Act, and the Cannabis and Controlled Substances Tort Claims Act to provide that persons engaged in donating or accepting, or packaging, repackaging, or labeling, prescription drugs to the extent permitted or required under the Prescription Drug Repository Program Act are exempt from provisions of those other Acts that might prohibit or otherwise regulate such activity.

House Committee Amendment No. 1 Replaces everything after the enacting clause. Creates the Illinois Drug Reuse Opportunity Program Act. Provides that, notwithstanding any other law or rule, donors may donate drugs to recipients and recipients may receive donated drugs from donors. Provides that recipients shall only dispense or administer drugs to eligible patients, further donate drugs to another recipient, or dispose of drugs in accordance with specified provisions. Provides that drugs donated for use under the Act are considered nonsaleable. Provides that, when dispensing a drugs to an eligible patient, the recipient must do so at no cost to the eligible patient, except that a reasonable handling fee may be charged. Provides that recipients may only dispense or administer a prescription drug or provide an over-the-counter drug if specified requirements are met. Provides that recipients shall, to the greatest extent practicable, dispense drugs received under the Act to priority patients. Provides that drugs may be accepted under the Act only if specified requirements are met. Contains requirements for the further donation of drugs by a recipient. Contains provisions regarding the disposition of specified drugs. Provides that nothing in the Act requires that a pharmacy or pharmacist be a recipient of drugs under the Act. Provides that the Act shall supersede any inconsistent law or rule for activities conducted under the Act. Contains other provisions. Amends the Pharmacy Practice Act, the Wholesale Drug Distribution Licensing Act, the Senior Pharmaceutical Assistance Act, the Illinois Food, Drug and Cosmetic Act, the Illinois Controlled Substances Act, and the Cannabis and Controlled Substances Tort Claims Act to provide that persons engaged in donating or accepting, or packaging, repackaging, or labeling, prescription drugs to the extent permitted or required under the Illinois Drug Reuse Opportunity Program Act are exempt from provisions of those other Acts that might prohibit or otherwise regulate such activity.

All Actions

Date Chamber Action 1/13/2021 House Filed with the Clerk by Rep. Will Guzzardi 1/14/2021 House First Reading 1/14/2021 House Referred to Rules Committee 1/19/2021 House Added Co-Sponsor Rep. Elizabeth Hernandez 1/19/2021 House Added Chief Co-Sponsor Rep. Jonathan Carroll 1/27/2021 House Added Co-Sponsor Rep. Margaret Croke 1/29/2021 House Added Co-Sponsor Rep. Maurice A. West, II 2/6/2021 House Added Co-Sponsor Rep. Dave Vella 2/6/2021 House Added Co-Sponsor Rep. Kelly M. Burke 2/6/2021 House Added Co-Sponsor Rep. Anne Stava-Murray 2/8/2021 House Added Co-Sponsor Rep. Andrew S. Chesney 2/8/2021 House Added Co-Sponsor Rep. Lindsey LaPointe 2/9/2021 House Added Co-Sponsor Rep. Camille Y. Lilly 2/9/2021 House Added Co-Sponsor Rep. Theresa Mah 2/9/2021 House Added Chief Co-Sponsor Rep. Tom Demmer 2/9/2021 House Added Co-Sponsor Rep. Barbara Hernandez 2/10/2021 House Added Co-Sponsor Rep. Maura Hirschauer 2/10/2021 House Added Co-Sponsor Rep. Michael Halpin 2/11/2021 House Added Co-Sponsor Rep. Greg Harris 2/16/2021 House Added Co-Sponsor Rep. Sam Yingling 2/16/2021 House Added Chief Co-Sponsor Rep. Lakesia Collins 2/16/2021 House Added Co-Sponsor Rep. Kelly M. Cassidy 2/16/2021 House Added Co-Sponsor Rep. Daniel Didech 2/19/2021 House Added Co-Sponsor Rep. Deb Conroy 2/22/2021 House Added Co-Sponsor Rep. Mike Murphy 2/23/2021 House Assigned to Human Services Committee 2/23/2021 House Added Co-Sponsor Rep. Thomas M. Bennett 2/23/2021 House Added Co-Sponsor Rep. Anna Moeller 3/1/2021 House Added Co-Sponsor Rep. Janet Yang Rohr 3/8/2021 House Added Co-Sponsor Rep. Amy Grant 3/10/2021 House House Committee Amendment No. 1 Filed with Clerk by Rep. Will Guzzardi 3/10/2021 House House Committee Amendment No. 1 Referred to Rules Committee 3/11/2021 House Added Co-Sponsor Rep. Bob Morgan 3/15/2021 House Added Co-Sponsor Rep. Charles Meier 3/16/2021 House House Committee Amendment No. 1 Rules Refers to Human Services Committee 3/16/2021 House Added Co-Sponsor Rep. Robyn Gabel 3/16/2021 House Added Co-Sponsor Rep. Tom Weber 3/16/2021 House Added Co-Sponsor Rep. Norine K. Hammond 3/16/2021 House Added Co-Sponsor Rep. Jaime M. Andrade, Jr. 3/16/2021 House Added Co-Sponsor Rep. Mary E. Flowers 3/16/2021 House Added Co-Sponsor Rep. Suzanne Ness 3/16/2021 House House Committee Amendment No. 1 Adopted in Human Services Committee; by Voice Vote 3/16/2021 House Do Pass as Amended / Consent Calendar Human Services Committee; 015-000-000 3/18/2021 House Placed on Calendar 2nd Reading - Consent Calendar 3/18/2021 House Added Co-Sponsor Rep. Joyce Mason 4/6/2021 House Added Co-Sponsor Rep. Carol Ammons 4/14/2021 House Second Reading - Consent Calendar 4/14/2021 House Held on Calendar Order of Second Reading - Consent Calendar 4/14/2021 House Added Co-Sponsor Rep. C.D. Davidsmeyer 4/14/2021 House Placed on Calendar Order of 3rd Reading - Consent Calendar 4/16/2021 House Third Reading - Consent Calendar - First Day 4/20/2021 House Added Co-Sponsor Rep. Katie Stuart 4/20/2021 House Added Co-Sponsor Rep. Ryan Spain 4/21/2021 House Third Reading - Consent Calendar - Passed 117-000-000 4/21/2021 Senate Arrive in Senate 4/21/2021 Senate Placed on Calendar Order of First Reading April 22, 2021 4/28/2021 Senate Chief Senate Sponsor Sen. Karina Villa 4/28/2021 Senate First Reading 4/28/2021 Senate Referred to Assignments 4/28/2021 Senate Added as Alternate Co-Sponsor Sen. Sue Rezin 4/29/2021 Senate Added as Alternate Chief Co-Sponsor Sen. Jacqueline Y. Collins 4/29/2021 Senate Added as Alternate Chief Co-Sponsor Sen. Dave Syverson 4/29/2021 Senate Added as Alternate Chief Co-Sponsor Sen. John Connor 4/29/2021 Senate Added as Alternate Chief Co-Sponsor Sen. Laura Ellman

HB 135

Short Description: INS CODE-BIRTH CONTROL

House Sponsors Rep. -Deb Conroy-Natalie A. Manley-Kelly M. Cassidy-Robyn Gabel, Lindsey LaPointe, Suzanne Ness, Margaret Croke, Will Guzzardi, Anna Moeller, Bob Morgan, Joyce Mason, , Maura Hirschauer, Katie Stuart, , Eva Dina Delgado, Anne Stava- Murray, Mark L. Walker, Daniel Didech, Jennifer Gong-Gershowitz, Elizabeth Hernandez, Lakesia Collins, Carol Ammons, Barbara Hernandez, Aaron M. Ortiz, , Jonathan Carroll, Delia C. Ramirez, Kambium Buckner and

Senate Sponsors (Sen. )

Synopsis As Introduced Amends the Department of Public Health Powers and Duties Law of the Civil Administrative Code of Illinois. Provides that the Director of Public Health, if a physician licensed to practice medicine in all its branches in Illinois, shall establish a standing order complete with the issuance of a prescription for a hormonal contraceptive in accordance with the requirements of the provisions. Provides that if the Director is not a physician licensed to practice medicine in all its branches in Illinois, the Medical Director of the Department of Public Health shall establish the standing order. Amends the Illinois Insurance Code. Requires a group or individual policy of accident and health insurance or managed care plan to provide coverage for patient care services provided by a pharmacist. Makes conforming changes in the State Employees Group Insurance Act of 1971, the Counties Code, the Illinois Municipal Code, and the School Code. Amends the Pharmacy Practice Act. Provides that the definition of "practice of pharmacy" includes the dispensing of hormonal contraceptives pursuant to the standing order under provisions of the Department of Public Health Powers and Duties Law of the Civil Administrative Code of Illinois. Amends the Illinois Public Aid Code. Requires the medical assistance program to cover patient care services provided by a pharmacist for hormonal contraceptives assessment and consultation. Effective January 1, 2022.

House Floor Amendment No. 1 Replaces everything after the enacting clause with the provisions of the introduced bill with the following changes. Further amends the Pharmacy Practice Act. Sets forth provisions concerning dispensation of hormonal contraceptives. Provides that the Department of Financial and Professional Regulation may adopt rules to implement the provisions. In provisions in the Illinois Public Aid Code concerning coverage for patient care services for hormonal contraceptives provided by a pharmacist, provides that the Department of Public Health (rather than the Director of Public Health) shall apply for any necessary federal waivers or approvals to implement the provisions by January 1, 2022. Provides that the Department shall submit to the Joint Committee on Administrative Rules administrative rules (rather than adopt administrative rules) as soon as practicable but no later than 6 months after federal approval is received (rather than no later than May 1, 2022). Removes changes to the Department of Public Health Powers and Duties Law of the Civil Administrative Code of Illinois. Removes language that provides that the provisions shall not be implemented until the receipt of all necessary federal waivers or approvals or until January 1, 2024, whichever comes first, and if federal approval is not obtained by January 1, 2024, the provisions shall be implemented using State funds.

All Actions

Date Chamber Action 1/13/2021 House Filed with the Clerk by Rep. Michelle Mussman 1/14/2021 House First Reading 1/14/2021 House Referred to Rules Committee 1/19/2021 House Added Co-Sponsor Rep. Lindsey LaPointe 2/16/2021 House Added Chief Co-Sponsor Rep. Deb Conroy 2/18/2021 House Added Co-Sponsor Rep. Suzanne Ness 2/23/2021 House Assigned to Health Care Licenses Committee 3/24/2021 House Do Pass / Short Debate Health Care Licenses Committee; 005-003-000 3/25/2021 House Added Chief Co-Sponsor Rep. Natalie A. Manley 3/26/2021 House Added Chief Co-Sponsor Rep. Kelly M. Cassidy 3/29/2021 House Added Chief Co-Sponsor Rep. Robyn Gabel 3/29/2021 House Chief Co-Sponsor Changed to Rep. Robyn Gabel 3/29/2021 House Added Co-Sponsor Rep. Margaret Croke 3/29/2021 House Added Co-Sponsor Rep. Will Guzzardi 3/29/2021 House Added Co-Sponsor Rep. Anna Moeller 3/29/2021 House Added Co-Sponsor Rep. Bob Morgan 3/29/2021 House Added Co-Sponsor Rep. Joyce Mason 3/29/2021 House Added Co-Sponsor Rep. Kathleen Willis 3/29/2021 House Added Co-Sponsor Rep. Maura Hirschauer 3/29/2021 House Added Co-Sponsor Rep. Katie Stuart 3/29/2021 House Added Co-Sponsor Rep. Terra Costa Howard 3/29/2021 House Added Co-Sponsor Rep. Eva Dina Delgado 3/29/2021 House Added Co-Sponsor Rep. Anne Stava-Murray 3/29/2021 House Added Co-Sponsor Rep. Mark L. Walker 3/29/2021 House Added Co-Sponsor Rep. Daniel Didech 3/29/2021 House Added Co-Sponsor Rep. Jennifer Gong-Gershowitz 3/29/2021 House Added Co-Sponsor Rep. Elizabeth Hernandez 4/8/2021 House Placed on Calendar 2nd Reading - Short Debate 4/14/2021 House Added Co-Sponsor Rep. Lakesia Collins 4/14/2021 House Added Co-Sponsor Rep. Carol Ammons 4/14/2021 House Added Co-Sponsor Rep. Barbara Hernandez 4/14/2021 House Added Co-Sponsor Rep. Aaron M. Ortiz 4/14/2021 House Added Co-Sponsor Rep. Dagmara Avelar 4/15/2021 House Added Co-Sponsor Rep. Jonathan Carroll 4/20/2021 House Added Co-Sponsor Rep. Delia C. Ramirez 4/20/2021 House Added Co-Sponsor Rep. Kambium Buckner 4/20/2021 House House Floor Amendment No. 1 Filed with Clerk by Rep. Michelle Mussman 4/20/2021 House House Floor Amendment No. 1 Referred to Rules Committee 4/20/2021 House House Floor Amendment No. 2 Filed with Clerk by Rep. Michelle Mussman 4/20/2021 House House Floor Amendment No. 2 Referred to Rules Committee 4/21/2021 House House Floor Amendment No. 1 Rules Refers to Health Care Licenses Committee 4/21/2021 House Second Reading - Short Debate 4/21/2021 House Held on Calendar Order of Second Reading - Short Debate 4/21/2021 House House Floor Amendment No. 1 Recommends Be Adopted Health Care Licenses Committee; 005-003-000 4/22/2021 House Added Co-Sponsor Rep. Emanuel Chris Welch 4/22/2021 House House Floor Amendment No. 1 Adopted 4/22/2021 House Placed on Calendar Order of 3rd Reading - Short Debate 4/22/2021 House Third Reading - Short Debate - Passed 070-042-000 4/22/2021 House House Floor Amendment No. 2 Tabled Pursuant to Rule 40 4/23/2021 Senate Arrive in Senate 4/23/2021 Senate Placed on Calendar Order of First Reading 4/23/2021 Senate Chief Senate Sponsor Sen. Melinda Bush 4/23/2021 Senate First Reading 4/23/2021 Senate Referred to Assignments

HB 711

Short Description: PRIOR AUTHORIZATION REFORM ACT

House Sponsors Rep. Greg Harris-Tom Demmer-William Davis-Anna Moeller-Ryan Spain, Keith R. Wheeler, Ann M. Williams, Robyn Gabel, Deb Conroy, Kelly M. Cassidy, , , Michael T. Marron, Jonathan Carroll, Elizabeth Hernandez, , , Martin J. Moylan, Michelle Mussman, , Deanne M. Mazzochi, Mike Murphy, Andrew S. Chesney, Norine K. Hammond, Nicholas K. Smith, Michael J. Madigan, Natalie A. Manley, Will Guzzardi, Jennifer Gong- Gershowitz, Margaret Croke, Katie Stuart, Bob Morgan, Lindsey LaPointe, Lawrence Walsh, Jr., , Maura Hirschauer, Debbie Meyers-Martin, Lakesia Collins, Barbara Hernandez, Tom Weber, Dagmara Avelar, Stephanie A. Kifowit, Daniel Didech, Tony McCombie, Thomas M. Bennett, , Amy Grant, Dave Vella, Michael Halpin, Terra Costa Howard, Jaime M. Andrade, Jr., , , Keith P. Sommer, , Charles Meier, Sam Yingling, Jehan Gordon-Booth, , Maurice A. West, II, Carol Ammons, Emanuel Chris Welch, Joyce Mason, and Camille Y. Lilly

Senate Sponsors (Sen. ---David Koehler-Antonio Muńoz, Hilton, Jacqueline Y. Collins, , , Kimberly A. Lightford, Donald P. DeWitte, Sue Rezin, Laura Fine and )

Synopsis As Introduced Creates the Prior Authorization Reform Act. Provides requirements concerning disclosure and review of prior authorization requirements, denial of claims or coverage by a utilization review organization, and the implementation of prior authorization requirements or restrictions. Provides requirements concerning a utilization review organization's obligations with respect to prior authorizations in nonurgent circumstances, urgent health care services, and emergency health care services. Provides that a utilization review organization shall not require prior authorization under specified circumstances. Provides requirements concerning the length of prior authorizations. Provides that health care services are automatically deemed authorized if a utilization review organization fails to comply with the requirements of the Act. Provides that the Director of Insurance may impose an administrative fine not to exceed $250,000 for violations of the Act. Defines terms. Amends the Illinois Insurance Code to change the definition of "emergency medical condition". Amends the Managed Care Reform and Patient Rights Act to provide that companies that transact accident and health insurance shall comply with specified requirements of the Managed Care Reform and Patient Rights Act. Amends the Illinois Public Aid Code to provide that all managed care organizations shall comply with the requirements of the Prior Authorization Reform Act. Makes other changes. Effective January 1, 2022.

House Floor Amendment No. 1 Replaces everything after the enacting clause with the provisions of the introduced bill with the following changes. Changes references from "utilization review organization" to "health insurance issuer" or "health insurance issuer or its contracted utilization review organization". Provides that a health insurance issuer or its contracted utilization review organization must ensure that all adverse determinations are made by a physician when the request is by a physician or a representative of a physician. Provides that a health insurance issuer shall periodically review its prior authorization requirements and consider removal of prior authorization requirements in specified circumstances (rather than a utilization review organization shall not require prior authorization in specified circumstances). In provisions concerning length of prior authorization approval, provides that a prior authorization approval shall be valid for the lesser of 12 months after the date the health care professional or health care provider receives the prior authorization approval or the length of treatment as determined by the patient's health care professional. In provisions concerning clinical review criteria of prior authorization requirements, removes language that provides that a utilization review organization shall seek input from actively practicing physicians representing major areas of the specialty who are not employees of the utilization review organization or consultants to the utilization review organization before establishing or substantially or materially altering written clinical review criteria. Removes language that provides that a utilization review organization shall not deny prior authorization of a health care service solely based on the grounds that a health care professional or health care provider judges a service, product, or procedure is medically appropriate for his or her patient even if it has not been formally approved for the specific condition being treated. In provisions concerning statistics that shall be made available regarding prior authorization approvals and denials, removes specified categories of information. In provisions concerning requirements applicable to the physician who can review consultations and appeals, removes language that provides that the physician must not be employed by a utilization review organization, be under contract with the utilization review organization other than to participate in one or more of the utilization review organization's health care professional networks or to perform reviews of appeals, or otherwise have any financial interest in the outcome of the appeal. Makes other changes. Effective January 1, 2022.

House Floor Amendment No. 2 Replaces everything after the enacting clause with the provisions of the introduced bill, and makes the following changes: In the Prior Authorization Reform Act, deletes a Section concerning obligations with respect to prior authorization concerning emergency health care services, and makes changes in provisions governing applicability; definitions; disclosure and review of prior authorization requirements; obligations with respect to prior authorizations; personnel qualified to make adverse determinations of a prior authorization request; adverse determinations; review of appeals; denials; length of prior authorization approval; continuity of care; effect of failure to comply with the Act; and administration and enforcement. Makes further changes in the Illinois Insurance Code in a Section concerning obligations under the Managed Care Reform and Patient Rights Act. Deletes changes made to the Managed Care Reform and Patient Rights Act in a Section concerning emergency services prior to stabilization. Effective January 1, 2022.

All Actions

Date Chamber Action 2/8/2021 House Filed with the Clerk by Rep. Greg Harris 2/8/2021 House Chief Co-Sponsor Rep. Tom Demmer 2/8/2021 House Chief Co-Sponsor Rep. William Davis 2/8/2021 House Chief Co-Sponsor Rep. Anna Moeller 2/8/2021 House Chief Co-Sponsor Rep. Ryan Spain 2/8/2021 House Co-Sponsor Rep. Keith R. Wheeler 2/8/2021 House Co-Sponsor Rep. Ann M. Williams 2/8/2021 House Co-Sponsor Rep. Robyn Gabel 2/8/2021 House Co-Sponsor Rep. Deb Conroy 2/8/2021 House Co-Sponsor Rep. Kelly M. Cassidy 2/8/2021 House Co-Sponsor Rep. Jeff Keicher 2/8/2021 House Co-Sponsor Rep. Mark Batinick 2/8/2021 House Co-Sponsor Rep. Michael T. Marron 2/8/2021 House Co-Sponsor Rep. Jonathan Carroll 2/8/2021 House Co-Sponsor Rep. Elizabeth Hernandez 2/8/2021 House Co-Sponsor Rep. Tim Butler 2/8/2021 House Co-Sponsor Rep. Frances Ann Hurley 2/8/2021 House Co-Sponsor Rep. Martin J. Moylan 2/8/2021 House Co-Sponsor Rep. Michelle Mussman 2/8/2021 House Co-Sponsor Rep. Justin Slaughter 2/8/2021 House Co-Sponsor Rep. Deanne M. Mazzochi 2/8/2021 House Co-Sponsor Rep. Mike Murphy 2/8/2021 House Co-Sponsor Rep. Andrew S. Chesney 2/8/2021 House Co-Sponsor Rep. Norine K. Hammond 2/8/2021 House Co-Sponsor Rep. Nicholas K. Smith 2/8/2021 House Co-Sponsor Rep. Michael J. Madigan 2/8/2021 House Co-Sponsor Rep. Natalie A. Manley 2/8/2021 House Co-Sponsor Rep. Will Guzzardi 2/8/2021 House Co-Sponsor Rep. Jennifer Gong-Gershowitz 2/8/2021 House Co-Sponsor Rep. Margaret Croke 2/8/2021 House Co-Sponsor Rep. Katie Stuart 2/8/2021 House Co-Sponsor Rep. Bob Morgan 2/8/2021 House Co-Sponsor Rep. Lindsey LaPointe 2/8/2021 House Co-Sponsor Rep. Lawrence Walsh, Jr. 2/8/2021 House First Reading 2/8/2021 House Referred to Rules Committee 2/10/2021 House Added Co-Sponsor Rep. Sue Scherer 2/10/2021 House Added Co-Sponsor Rep. Maura Hirschauer 2/11/2021 House Added Co-Sponsor Rep. Debbie Meyers-Martin 2/11/2021 House Added Co-Sponsor Rep. Lakesia Collins 2/16/2021 House Added Co-Sponsor Rep. Barbara Hernandez 2/16/2021 House Added Co-Sponsor Rep. Tom Weber 2/16/2021 House Added Co-Sponsor Rep. Dagmara Avelar 2/16/2021 House Added Co-Sponsor Rep. Stephanie A. Kifowit 2/18/2021 House Added Co-Sponsor Rep. Daniel Didech 2/18/2021 House Added Co-Sponsor Rep. Tony McCombie 2/18/2021 House Added Co-Sponsor Rep. Thomas M. Bennett 2/19/2021 House Added Co-Sponsor Rep. Amy Elik 2/19/2021 House Added Co-Sponsor Rep. Amy Grant 2/24/2021 House Added Co-Sponsor Rep. Dave Vella 2/25/2021 House Added Co-Sponsor Rep. Michael Halpin 2/26/2021 House Added Co-Sponsor Rep. Terra Costa Howard 2/28/2021 House Added Co-Sponsor Rep. Jaime M. Andrade, Jr. 3/2/2021 House Assigned to Human Services Committee 3/3/2021 House Added Co-Sponsor Rep. Dave Severin 3/4/2021 House Added Co-Sponsor Rep. Dan Caulkins 3/9/2021 House Do Pass / Short Debate Human Services Committee; 015-000-000 3/12/2021 House Added Co-Sponsor Rep. Keith P. Sommer 3/12/2021 House Added Co-Sponsor Rep. Adam Niemerg 3/16/2021 House Added Co-Sponsor Rep. Charles Meier 3/17/2021 House Placed on Calendar 2nd Reading - Short Debate 3/17/2021 House Added Co-Sponsor Rep. Sam Yingling 3/18/2021 House Added Co-Sponsor Rep. Jehan Gordon-Booth 4/1/2021 House Added Co-Sponsor Rep. Chris Bos 4/7/2021 House Added Co-Sponsor Rep. Maurice A. West, II 4/7/2021 House House Floor Amendment No. 1 Filed with Clerk by Rep. Greg Harris 4/7/2021 House House Floor Amendment No. 1 Referred to Rules Committee 4/13/2021 House House Floor Amendment No. 1 Rules Refers to Human Services Committee 4/14/2021 House House Floor Amendment No. 1 Recommends Be Adopted Human Services Committee; 012-000-000 4/20/2021 House Added Co-Sponsor Rep. Carol Ammons 4/20/2021 House Added Co-Sponsor Rep. Emanuel Chris Welch 4/20/2021 House House Floor Amendment No. 2 Filed with Clerk by Rep. Greg Harris 4/20/2021 House House Floor Amendment No. 2 Referred to Rules Committee 4/20/2021 House Second Reading - Short Debate 4/20/2021 House House Floor Amendment No. 1 Adopted 4/20/2021 House Placed on Calendar Order of 3rd Reading - Short Debate 4/20/2021 House Added Co-Sponsor Rep. Joyce Mason 4/21/2021 House Recalled to Second Reading - Short Debate 4/21/2021 House Added Co-Sponsor Rep. Seth Lewis 4/21/2021 House House Floor Amendment No. 2 Recommends Be Adopted Rules Committee; 005-000-000 4/21/2021 House House Floor Amendment No. 2 Adopted 4/21/2021 House Placed on Calendar Order of 3rd Reading - Short Debate 4/21/2021 House Third Reading - Short Debate - Passed 117-000-000 4/21/2021 House Added Co-Sponsor Rep. Camille Y. Lilly 4/21/2021 Senate Arrive in Senate 4/21/2021 Senate Placed on Calendar Order of First Reading April 22, 2021 4/22/2021 Senate Chief Senate Sponsor Sen. Linda Holmes 4/22/2021 Senate First Reading 4/22/2021 Senate Referred to Assignments 4/22/2021 Senate Added as Alternate Chief Co-Sponsor Sen. Dale Fowler 4/27/2021 Senate Added as Alternate Chief Co-Sponsor Sen. Cristina Castro 4/27/2021 Senate Added as Alternate Chief Co-Sponsor Sen. David Koehler 4/27/2021 Senate Added as Alternate Chief Co-Sponsor Sen. Antonio Muńoz 4/27/2021 Senate Added as Alternate Co-Sponsor Sen. Suzy Glowiak Hilton 4/27/2021 Senate Added as Alternate Co-Sponsor Sen. Jacqueline Y. Collins 4/27/2021 Senate Added as Alternate Co-Sponsor Sen. Rachelle Crowe 4/28/2021 Senate Added as Alternate Co-Sponsor Sen. Patricia Van Pelt 4/28/2021 Senate Added as Alternate Co-Sponsor Sen. Kimberly A. Lightford 4/28/2021 Senate Assigned to Insurance 4/28/2021 Senate Added as Alternate Co-Sponsor Sen. Donald P. DeWitte 4/28/2021 Senate Added as Alternate Co-Sponsor Sen. Sue Rezin 4/29/2021 Senate Added as Alternate Co-Sponsor Sen. Laura Fine 4/29/2021 Senate Added as Alternate Co-Sponsor Sen. Adriane Johnson

HB 1745

Short Description: INS-PRESCRIPTION DRUG BENEFITS

House Sponsors Rep. Greg Harris-Marcus C. Evans, Jr.-Debbie Meyers-Martin-Nicholas K. Smith, Theresa Mah, Dagmara Avelar, Jonathan Carroll, Joyce Mason, Stephanie A. Kifowit, Sue Scherer, Will Guzzardi, Mark L. Walker, Daniel Didech, Kelly M. Cassidy, Martin J. Moylan, Anne Stava-Murray, Michelle Mussman, William Davis, Bob Morgan, , Margaret Croke, Deb Conroy, Maura Hirschauer, Katie Stuart, Lindsey LaPointe, Thaddeus Jones, Anthony DeLuca, Michael Halpin, Suzanne Ness, Elizabeth Hernandez, Dave Vella, Emanuel Chris Welch and Janet Yang Rohr

Senate Sponsors (Sen. , III, Antonio Muńoz- and Laura Fine)

Synopsis As Introduced Amends the Managed Care Reform and Patient Rights Act. Requires health insurance carriers that provide coverage for prescription drugs to ensure that, within service areas and levels of coverage specified by federal law, at least half of individual and group plans meet one or more of the following criteria: apply a pre-deductible and flat-dollar copayment structure to the entire drug benefit, limit a beneficiary's monthly out-of-pocket financial responsibility for prescription drugs to a specified amount, or limit a beneficiary's annual out-of-pocket financial responsibility for prescription drugs to a specified amount. Provides that all plans for prescription drugs offered under the amendatory Act must be clearly and appropriately named, marketed in the same manner as other plans offered by the health insurance carrier, and offered for purchase to any individual and group plan sponsor. Effective January 1, 2022.

House Committee Amendment No. 1 Replaces everything after the enacting clause. Amends the Managed Care Reform and Patient Rights Act. In provisions concerning individual health plans that provide coverage for prescription drugs, provides that beginning January 1, 2023, health insurance carriers shall ensure that at least 10% of individual health care plans offered in each applicable service area apply a flat-dollar copayment structure to the entire drug benefit; and beginning January 1, 2024, health insurance carriers shall ensure that at least 25% of individual health care plans offered in each applicable service area apply a flat-dollar copayment structure to the entire drug benefit. In provisions concerning group health plans that provide coverage for prescription drugs, provides that beginning January 1, 2023, health insurance carriers shall offer at least one group health plan in each applicable service area that applies a flat-dollar copayment structure to the entire drug benefit; and beginning January 1, 2024, health insurance carriers shall offer at least 2 group health plans in each applicable service area that apply a flat-dollar copayment structure to the entire drug benefit. Provides that the flat-dollar copayment structure for prescription drugs must be applied pre-deductible and be reasonably graduated and proportionately related in all tier levels such that the copayment structure as a whole does not discriminate against or discourage the enrollment of individuals with significant health care needs. Requires the health insurance carriers to clearly and appropriately name the plans to aid in individual or group plan selection. Requires the health insurance carriers to market the plans in the same manner as their other plans. Requires the Department of Insurance to adopt rules necessary to implement and enforce the provisions. Effective January 1, 2023.

All Actions

Date Chamber Action 2/11/2021 House Filed with the Clerk by Rep. Greg Harris 2/16/2021 House Added Co-Sponsor Rep. Theresa Mah 2/16/2021 House Added Co-Sponsor Rep. Dagmara Avelar 2/16/2021 House Added Co-Sponsor Rep. Jonathan Carroll 2/16/2021 House Added Co-Sponsor Rep. Joyce Mason 2/16/2021 House Added Co-Sponsor Rep. Stephanie A. Kifowit 2/16/2021 House Added Co-Sponsor Rep. Sue Scherer 2/17/2021 House First Reading 2/17/2021 House Referred to Rules Committee 2/26/2021 House Added Co-Sponsor Rep. Will Guzzardi 2/26/2021 House Added Chief Co-Sponsor Rep. Marcus C. Evans, Jr. 2/26/2021 House Added Co-Sponsor Rep. Mark L. Walker 2/26/2021 House Added Co-Sponsor Rep. Daniel Didech 2/26/2021 House Added Co-Sponsor Rep. Kelly M. Cassidy 2/26/2021 House Added Co-Sponsor Rep. Martin J. Moylan 2/26/2021 House Added Co-Sponsor Rep. Anne Stava-Murray 2/28/2021 House Added Co-Sponsor Rep. Michelle Mussman 3/2/2021 House Added Co-Sponsor Rep. William Davis 3/2/2021 House Added Co-Sponsor Rep. Bob Morgan 3/4/2021 House Added Co-Sponsor Rep. Rita Mayfield 3/8/2021 House Added Co-Sponsor Rep. Margaret Croke 3/9/2021 House Assigned to Prescription Drug Affordability & Accessibility Committee 3/12/2021 House Added Chief Co-Sponsor Rep. Debbie Meyers-Martin 3/12/2021 House Added Co-Sponsor Rep. Deb Conroy 3/12/2021 House Added Co-Sponsor Rep. Maura Hirschauer 3/17/2021 House Added Co-Sponsor Rep. Katie Stuart 3/18/2021 House Added Co-Sponsor Rep. Lindsey LaPointe 3/19/2021 House House Committee Amendment No. 1 Filed with Clerk by Rep. Greg Harris 3/19/2021 House House Committee Amendment No. 1 Referred to Rules Committee 3/22/2021 House Added Co-Sponsor Rep. Thaddeus Jones 3/23/2021 House House Committee Amendment No. 1 Rules Refers to Prescription Drug Affordability & Accessibility Committee 3/25/2021 House House Committee Amendment No. 1 Adopted in Prescription Drug Affordability & Accessibility Committee; by Voice Vote 3/25/2021 House Do Pass as Amended / Consent Calendar Prescription Drug Affordability & Accessibility Committee; 018-000-000 3/30/2021 House Added Co-Sponsor Rep. Anthony DeLuca 4/8/2021 House Placed on Calendar 2nd Reading - Consent Calendar 4/12/2021 House Added Co-Sponsor Rep. Michael Halpin 4/14/2021 House Second Reading - Consent Calendar 4/14/2021 House Held on Calendar Order of Second Reading - Consent Calendar 4/14/2021 House Placed on Calendar Order of 3rd Reading - Consent Calendar 4/16/2021 House Third Reading - Consent Calendar - First Day 4/20/2021 House Added Co-Sponsor Rep. Suzanne Ness 4/20/2021 House Added Co-Sponsor Rep. Elizabeth Hernandez 4/20/2021 House Added Co-Sponsor Rep. Dave Vella 4/20/2021 House Added Co-Sponsor Rep. Emanuel Chris Welch 4/20/2021 House Added Chief Co-Sponsor Rep. Nicholas K. Smith 4/21/2021 House Added Co-Sponsor Rep. Janet Yang Rohr 4/21/2021 House Third Reading - Consent Calendar - Passed 117-000-000 4/21/2021 Senate Arrive in Senate 4/21/2021 Senate Placed on Calendar Order of First Reading April 22, 2021 4/22/2021 Senate Chief Senate Sponsor Sen. Napoleon Harris, III 4/22/2021 Senate First Reading 4/22/2021 Senate Referred to Assignments 4/28/2021 Senate Added as Alternate Co-Sponsor Sen. Antonio Muńoz 4/29/2021 Senate Added as Alternate Chief Co-Sponsor Sen. Mike Simmons 4/29/2021 Senate Added as Alternate Co-Sponsor Sen. Laura Fine

HB 2589

Short Description: SUBSTANCE USE DISORDER-OPIOIDS

House Sponsors Rep. Deb Conroy-La Shawn K. Ford and Angelica Guerrero-Cuellar

Senate Sponsors (Sen. Laura Fine)

Synopsis As Introduced Amends the Substance Use Disorder Act. Provides that a health care professional or other person acting under the direction of a health care professional may store and, without generating or affixing a patient-specific label, dispense an opioid antagonist to a patient in a hospital, hospital affiliate, or ambulatory treatment center if certain patient information is provided to the patient. Makes changes to provisions concerning the grants awarded under the Drug Overdose Prevention Program. Provides that the Department of Human Services shall (rather than may) develop policy or best practice guidelines for identification of at-risk individuals through SBIRT (Screening, Brief Intervention, and Referral to Treatment) and contract or billing requirements for SBIRT. Amends the Medical Assistance Article of the Illinois Public Aid Code. Requires the Department of Healthcare and Family Services to develop and seek federal approval of a SBIRT benefit for which qualified providers shall be reimbursed under the medical assistance program; and to develop a methodology and bundled reimbursement rate for SBIRT services. Provides that pharmacy fees or hospital fees related to the distribution of opioid antagonists prescribed for the treatment of an opioid overdose shall be covered under the medical assistance program. Amends the Illinois Insurance Code. Provides that an individual or group policy of accident and health insurance amended, delivered, issued, or renewed in this State that provides coverage for prescription drugs must provide coverage for all opioid antagonists approved by the U.S. Food and Drug Administration (FDA). Requires health care plans that provide coverage for hospital expenses to also reimburse a hospital for the hospital's cost of any FDA approved opioid antagonist.

All Actions

Date Chamber Action 2/17/2021 House Filed with the Clerk by Rep. Deb Conroy 2/19/2021 House First Reading 2/19/2021 House Referred to Rules Committee 3/9/2021 House Assigned to Mental Health & Addiction Committee 3/19/2021 House Do Pass / Consent Calendar Mental Health & Addiction Committee; 015- 000-000 3/24/2021 House Added Co-Sponsor Rep. Angelica Guerrero-Cuellar 4/8/2021 House Placed on Calendar 2nd Reading - Consent Calendar 4/15/2021 House Second Reading - Consent Calendar 4/15/2021 House Held on Calendar Order of Second Reading - Consent Calendar 4/16/2021 House Placed on Calendar Order of 3rd Reading - Consent Calendar 4/19/2021 House Added Chief Co-Sponsor Rep. La Shawn K. Ford 4/21/2021 House Third Reading - Consent Calendar - First Day 4/22/2021 House Third Reading - Consent Calendar - Passed 113-000-000 4/23/2021 Senate Arrive in Senate 4/23/2021 Senate Placed on Calendar Order of First Reading 4/23/2021 Senate Chief Senate Sponsor Sen. Laura Fine 4/23/2021 Senate First Reading 4/23/2021 Senate Referred to Assignments

HB 3497

Short Description: REGULATION-TECH

House Sponsors Rep. Theresa Mah

Senate Sponsors (Sen. Neil Anderson)

Synopsis As Introduced Amends the Pharmacy Practice Act. Makes a technical change in a Section concerning the State Board of Pharmacy.

House Floor Amendment No. 2 Replaces everything after the enacting clause. Amends the Pharmacy Practice Act. Provides that the State Board of Pharmacy shall consist of 11 members (rather than 9 members). Provides that 8 members (rather than 7 members) shall be licensed pharmacists. Provides that one of the licensed pharmacists shall have a primary site for the practice of pharmacy at an inpatient hospital pharmacy. Adds one member who is a pharmacy technician.

All Actions

Date Chamber Action 2/19/2021 House Filed with the Clerk by Rep. Theresa Mah 2/22/2021 House First Reading 2/22/2021 House Referred to Rules Committee 3/16/2021 House Assigned to Executive Committee 3/24/2021 House House Committee Amendment No. 1 Filed with Clerk by Rep. Theresa Mah 3/24/2021 House House Committee Amendment No. 1 Referred to Rules Committee 3/27/2021 House Rule 19(a) / Re-referred to Rules Committee 4/6/2021 House Assigned to Executive Committee 4/6/2021 House House Committee Amendment No. 1 Rules Refers to Executive Committee 4/6/2021 House Committee Deadline Extended-Rule 9(b) April 23, 2021 4/8/2021 House Re-assigned to Health Care Licenses Committee 4/8/2021 House House Committee Amendment No. 1 Re-assigned to Health Care Licenses Committee 4/14/2021 House Do Pass / Short Debate Health Care Licenses Committee; 008-000-000 4/14/2021 House House Committee Amendment No. 1 Tabled Pursuant to Rule 40 4/14/2021 House Placed on Calendar 2nd Reading - Short Debate 4/15/2021 House House Floor Amendment No. 2 Filed with Clerk by Rep. Theresa Mah 4/15/2021 House House Floor Amendment No. 2 Referred to Rules Committee 4/20/2021 House House Floor Amendment No. 2 Recommends Be Adopted Rules Committee; 005-000-000 4/20/2021 House Second Reading - Short Debate 4/20/2021 House House Floor Amendment No. 2 Adopted 4/20/2021 House Placed on Calendar Order of 3rd Reading - Short Debate 4/21/2021 House Third Reading - Short Debate - Passed 117-000-000 4/21/2021 Senate Arrive in Senate 4/21/2021 Senate Placed on Calendar Order of First Reading April 22, 2021 4/22/2021 Senate Chief Senate Sponsor Sen. Neil Anderson 4/22/2021 Senate First Reading 4/22/2021 Senate Referred to Assignments

SB 579

Committee Hearing: Human Services Committee Hearing May 5 2021 8:30AM www.ilga.gov Virtual Room 2 Springfield, IL

Short Description: FACILITY-PROVIDED MEDICATIONS

Senate Sponsors Sen. Laura Fine-Ann Gillespie-Julie A. Morrison-David Koehler-Laura M. Murphy, , , and

House Sponsors (Rep. Jennifer Gong-Gershowitz-Carol Ammons)

Synopsis As Introduced Amends the University of Illinois Hospital Act, the Ambulatory Surgical Treatment Center Act, the Hospital Licensing Act, and the Pharmacy Practice Act. Requires hospitals and facilities to offer a patient any unused portion of a facility-provided medication upon discharge when it is administered to a patient at the hospital or facility and is required for continuing treatment. Defines "facility-provided medication". Provides that an unused portion of a facility-provided medication required for continuing treatment must be provided to a patient upon discharge when the facility-provided medication is ordered at least 24 hours in advance for surgical procedures. Requires facility-medications to be consistent with labeling requirements under specified provisions of the Pharmacy Practice Act. Provides that if a facility-provided medication is used in an operating room or emergency department setting, the prescriber is responsible for counseling the patient on its proper use and administration and the requirement of pharmacist counseling is waived. Effective July 1, 2021.

Senate Committee Amendment No. 1 Provides that a facility-provided medication must be ordered at least 24 hours in advance for a surgical procedure and be administered to (rather than only administered to) a patient at the facility for any unused portion of the facility-provided medication to be offered to the patient upon discharge when it is required for continuing treatment.

All Actions Date Chamber Action 2/23/2021 Senate Filed with Secretary by Sen. Laura Fine 2/23/2021 Senate First Reading 2/23/2021 Senate Referred to Assignments 3/3/2021 Senate Assigned to Health 3/9/2021 Senate To Subcommittee on Public Health 3/11/2021 Senate Senate Committee Amendment No. 1 Filed with Secretary by Sen. Laura Fine 3/11/2021 Senate Senate Committee Amendment No. 1 Referred to Assignments 3/16/2021 Senate Senate Committee Amendment No. 1 Assignments Refers to Health 3/22/2021 Senate Reported Back To Health; 005-000-000 3/23/2021 Senate Added as Chief Co-Sponsor Sen. Ann Gillespie 3/23/2021 Senate Added as Chief Co-Sponsor Sen. Julie A. Morrison 3/23/2021 Senate Senate Committee Amendment No. 1 Adopted 3/23/2021 Senate Added as Chief Co-Sponsor Sen. David Koehler 3/23/2021 Senate Added as Chief Co-Sponsor Sen. Laura M. Murphy 3/23/2021 Senate Added as Co-Sponsor Sen. Darren Bailey 3/24/2021 Senate Do Pass as Amended Health; 013-000-000 3/24/2021 Senate Placed on Calendar Order of 2nd Reading March 25, 2021 4/14/2021 Senate Second Reading 4/14/2021 Senate Placed on Calendar Order of 3rd Reading ** April 15, 2021 4/14/2021 Senate Added as Co-Sponsor Sen. Christopher Belt 4/20/2021 Senate Added as Co-Sponsor Sen. Meg Loughran Cappel 4/20/2021 Senate Added as Co-Sponsor Sen. Chapin Rose 4/21/2021 Senate Third Reading - Passed; 056-000-000 4/22/2021 House Arrived in House 4/22/2021 House Chief House Sponsor Rep. Jennifer Gong-Gershowitz 4/23/2021 House First Reading 4/23/2021 House Referred to Rules Committee 4/28/2021 House Added Alternate Chief Co-Sponsor Rep. Carol Ammons 4/28/2021 House Assigned to Human Services Committee

SB 2008

Short Description: INS-PHARMACY BENEFIT MANAGERS

Senate Sponsors Sen. David Koehler-Linda Holmes-Laura M. Murphy, , Cristina Castro, , Sally J. Turner, Steve McClure, Dale Fowler, Doris Turner-Napoleon Harris, III, Darren Bailey, Laura Fine, Chapin Rose-Michael E. Hastings, Melinda Bush, Julie A. Morrison and Steven M. Landek

Synopsis As Introduced Amends the Illinois Insurance Code. Provides that if a generic equivalent for a brand name drug is approved by the federal Food and Drug Administration, plans that provide coverage for prescription drugs through the use of a drug formulary that are amended, delivered, issued, or renewed in the State on or after January 1, 2022 shall comply with specified requirements. Provides that the Department of Insurance may adopt rules to implement provisions concerning notice of change of drug formulary. In provisions concerning a contract between a health insurer and a pharmacy benefit manager, provides that a pharmacy benefit manager must update and publish maximum allowable cost pricing information according to specified requirements, must provide a reasonable administrative appeal procedure to allow pharmacies to challenge maximum allowable costs, and must comply with specified requirements if an appeal is denied. Sets forth provisions concerning pharmacy benefit manager contracts; specified requirements that a pharmacy benefit manager shall comply with; specified requirements that an auditing entity shall comply with when conducting a pharmacy audit; and specified requirements concerning pharmacy network access standards. Provides that a violation of specified provisions is an unfair method of competition and unfair and deceptive act or practice in the business of insurance. Sets forth provisions concerning applicability of the Pharmacy Benefit Managers Article of the Illinois Insurance Code, and provisions concerning fiduciary responsibility of a pharmacy benefit manager. Defines terms. Makes other changes. Amends the Illinois Public Aid Code. Sets forth provisions concerning reimbursement of professional dispensing fees and acquisition costs for pharmacy providers.

Senate Committee Amendment No. 1 Replaces everything after the enacting clause with the provisions of the introduced bill with the following changes. Provides that a pharmacy may not be subject to a chargeback or recoupment for a clerical or recordkeeping error in a required document or record unless the pharmacy benefit manager can provide proof of intent to commit fraud or such error results in actual financial harm to the pharmacy benefit manager, a health plan managed by the pharmacy benefit manager, or a consumer. Removes various provisions concerning pharmacy benefit manager contracts. Defines "spread pricing". Removes various definitions. Amends the Network Adequacy and Transparency Act. In provisions concerning pharmacy payments under the Medical Assistance Article of the Illinois Public Aid Code, provides that the Department of Healthcare and Family Services may reimburse a pharmacy owned by an entity participating in the federal Drug Pricing Program under the federal Public Health Service Act, for drugs purchased under the Program, an amount equal to or greater than the ceiling price calculated under the federal Act. Provides that all Medicaid managed care organizations must reimburse a pharmacy participating in the federal Drug Pricing Program, for drugs purchased under the Program, an amount equal to or greater than the current national average drug acquisition cost listing for the pharmaceutical product. Provides that the Department, a Medicaid managed care organization, and a pharmacy benefit manager under contract with a Medicaid managed care provider to reimburse pharmacy providers shall not prohibit any entity or pharmacy participating in the federal Drug Pricing Program from using drugs purchased under the federal Act when submitting claims for pharmaceutical reimbursement. Makes other changes.

All Actions Date Chamber Action 2/26/2021 Senate Filed with Secretary by Sen. David Koehler 2/26/2021 Senate First Reading 2/26/2021 Senate Referred to Assignments 3/5/2021 Senate Added as Chief Co-Sponsor Sen. Linda Holmes 3/5/2021 Senate Added as Chief Co-Sponsor Sen. Laura M. Murphy 3/5/2021 Senate Added as Co-Sponsor Sen. Sara Feigenholtz 3/9/2021 Senate Added as Co-Sponsor Sen. Cristina Castro 3/9/2021 Senate Added as Co-Sponsor Sen. Antonio Muńoz 3/9/2021 Senate Added as Co-Sponsor Sen. Mattie Hunter 3/16/2021 Senate Added as Co-Sponsor Sen. Sally J. Turner 3/16/2021 Senate Assigned to Insurance 3/16/2021 Senate Added as Co-Sponsor Sen. Steve McClure 3/17/2021 Senate Added as Co-Sponsor Sen. Dale Fowler 3/18/2021 Senate Added as Co-Sponsor Sen. Doris Turner 3/18/2021 Senate Added as Chief Co-Sponsor Sen. Napoleon Harris, III 3/23/2021 Senate Added as Co-Sponsor Sen. Darren Bailey 3/24/2021 Senate Postponed - Insurance 3/25/2021 Senate Added as Co-Sponsor Sen. Laura Fine 4/7/2021 Senate Added as Co-Sponsor Sen. Chapin Rose 4/12/2021 Senate Senate Committee Amendment No. 1 Filed with Secretary by Sen. David Koehler 4/12/2021 Senate Senate Committee Amendment No. 1 Referred to Assignments 4/13/2021 Senate Added as Chief Co-Sponsor Sen. Michael E. Hastings 4/13/2021 Senate Added as Co-Sponsor Sen. Melinda Bush 4/14/2021 Senate Senate Committee Amendment No. 1 Assignments Refers to Insurance 4/14/2021 Senate Sponsor Removed Sen. Antonio Muńoz 4/14/2021 Senate Added as Co-Sponsor Sen. Julie A. Morrison 4/14/2021 Senate Senate Committee Amendment No. 1 Postponed - Insurance 4/15/2021 Senate Postponed - Insurance 4/15/2021 Senate Added as Co-Sponsor Sen. Steven M. Landek 4/16/2021 Senate Senate Committee Amendment No. 2 Filed with Secretary by Sen. David Koehler 4/16/2021 Senate Senate Committee Amendment No. 2 Referred to Assignments 4/16/2021 Senate Rule 2-10 Committee Deadline Established As April 23, 2021 4/20/2021 Senate Senate Committee Amendment No. 2 Assignments Refers to Insurance 4/21/2021 Senate Senate Committee Amendment No. 1 Adopted 4/21/2021 Senate Postponed - Insurance 4/23/2021 Senate Rule 2-10 Committee/3rd Reading Deadline Established As April 30, 2021

Totals: 8 - (House Bills: 6) (Senate Bills: 2) (Other Bills: 0)